Mario joined Ampersand in 2018. Previously, he worked at PNC Riverarch Capital, a middle-market private equity firm, and TM Capital, a middle-market investment bank, where he focused on healthcare M&A transactions. Mario holds a B.S. in finance with a concentration in economics from the Rochester Institute of Technology. Mario’s current and past Board seats include AcuraBio, Biologos, iuvo BioScience, NuvinkaDx,, and Precision Coating.
